This hypothesis is also supported by recent evidence in BWS patients on the loss of the chromatin structure of the IGF2/H19 and CDKN1C/KCNQ1OT1 domains, which disrupts the fine-tuned control of gene expression in the two clusters [41]. This evidence concerns the gene IGF2 and Beckwith-Wiedemann syndrome.